NCT02552888View on ClinicalTrials.gov

Nitrite, Isoquercetin and Endothelial Dysfunction (NICE) Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Chronic Kidney Disease
Interventions
DRUG

Immediate release sodium nitrite

Immediate release sodium nitrite 40 mg by mouth twice per day

DIETARY_SUPPLEMENT

Isoquercetin

Isoquercetin 225 mg by mouth once per day

OTHER

placebos

placebos

Trial Locations (1)

70112

Tulane School of Medicine, New Orleans

All Listed Sponsors
collaborator

National Institute of General Medical Sciences (NIGMS)

NIH

lead

Tulane University

OTHER

NCT02552888 - Nitrite, Isoquercetin and Endothelial Dysfunction (NICE) Trial | Biotech Hunter | Biotech Hunter